# Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study

> **NCT07566975** · — · RECRUITING · sponsor: **Neuro-Ophthalmology of Texas** · enrollment: 50 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **OTHER:** Cyclosporine ophthalmic solution 0.1%

## Key facts

- **NCT ID:** NCT07566975
- **Lead sponsor:** Neuro-Ophthalmology of Texas
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566975, "Real-World Assessment of VEVYE® for Short-Term Symptom and Sign Improvement of Dry Eye Disease in a Neuro-Ophthalmology Clinic: A 6-Month Prospective Observational Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07566975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*